Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma

Israel Medical Association Journal

Volumn 10, Issue 6, 2008, Pages 448-452

  Lieberman, Sivan ^a   Sella, Tamar ^a   Maly, Bella ^a   Sosna, Jacob ^a   Uziely, Beatrice ^a   Sklair Levy, Miri ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Biopsy; Breast cancer; Magnetic resonance imaging; Occult primary tumor

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BILATERAL CANCER; BONE METASTASIS; BREAST BIOPSY; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER SIZE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; ECHOMAMMOGRAPHY; EYE CANCER; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PARANEOPLASTIC SYNDROME; PARTIAL MASTECTOMY; PROBABILITY; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS;

ADULT; AGED; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; RETROSPECTIVE STUDIES;

EID: 48949103987     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Baron PL, Moore MP, Kinne DW, Candela FC, Osborne MP, Petrek JA. Occult breast cancer presenting with axillary metastases. Updated management. Arch Surg 1990;125:210-14.
2. Blair S, McElroy M. Middleton MS, et al. The efficacy of breast MRI in predicting breast conservation therapy. J Surg Oncol 2006;94:220-5.
3. Padhani AR, Hayes C, Assersohn L, et al. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 2006;239:361-74.
4. Plevritis SK, Kurian AW, Sigal BM, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 2006;295:2374-84.
5. Galinsky D, Kisselgoff D, Sella T, Peretz T, Libson E, Sklair-Levy M. Effect of breast magnetic resonance imaging on the clinical management of breast cancer. IMAJ 2005;7:700-3.
6. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89.
7. Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KI. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005;12:1045-53.
8. Cisneros-Reig I, Laguna Sastre M, Alcalde Sanchez M, et al. Bilateral occult breast carcinoma: a second primary tumour or contralateral tumour metastasis? Eur J Surg 2001;167:312-15.
9. Henry-Tillman RS, Harms SE, Westbrook KC, Korourian S, Klimberg VS. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg 1999;178:496-500.
10. Obdeijn IM, Brouwers-Kuyper EM, Tilanus-Linthorst MM, Wiggers T, Oudkerk M. MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol 2000;174:1079-84.
11. Olson JA, Jr., Morris EA, Van Zee KJ, Linehan DC, Borgen PI. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000;7:411-15.
12. Orel SG, Weinstein SP, Schnall MD, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999;212;543-9.
13. Schelfout K, Kersschot E, Van Goethem M, et al. Breast MR imaging in a patient with unilateral axillary lymphadenopathy and unknown primary malignancy. Eur Radiol 2003;13:2128-32.
14. Schorn C, Fischer U, Luftner-Nagel S, Westerhof JP, Grabbe E. MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol 1999;9:470-3.
15. Tilanus-Linthorst MM, Obdeijn AI, Bontenbal M, Oudkerk M. MRI in patients with axillary metastases of occult breast carcinoma. Breast Cancer Res Treat 1997;44:179-82.
16. Erguvan-Dogan B, Whitman GJ, Kushwaha AC, Phelps MJ, Dempsey PJ. BI-RADS-MRI: a primer. AJR Am J Roentgenol 2006;187: W152-60.
17. Shulman SG, March DE. Ultrasound-guided breast interventions: accuracy of biopsy techniques and applications in patient management. Semin Ultrasound CT MR 2006;27:298-307.
18. Orel SG, Schnall MD, Newman RW, Powell CM, Torosian MH, Rosato EF. MR imaging-guided localization and biopsy of breast lesions: initial experience. Radiology 1994;193:97-102.
19. Le-Petross HT. Breast MRI as a screening tool: the appropriate role. J Natl Compr Canc Netw 2006;4:523-6.
20. Campana F, Fourquet A, Ashby MA, et al. Presentation of axillary lymphadenopathy without detectable breast primary (TO NIb breast cancer): experience at Institut Curie. Radiother Oncol 1989;15:321-5.
21. Ellerbroek N, Holmes F, Singletary E, Evans H, Oswald M, McNeese M. Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin. Cancer 1990;66:1461-7.
22. Zuiani C, Francescutti GE, Londero V, Zunnui I, Bazzocchi M. Ductal carcinoma in situ: is there a role for MRI? J Exp Clin Cancer Res 2002;21:89-95.
23. Iwasaki Y, Fukutomi T, Akashi-Tanaka S, Nanasawa T, Tsuda H. Axillary node metastasis from TINOMO breast cancer: possible avoidance of dissection in a subgroup. Jpn J Clin Oncol 1998; 28:601-3.
24. DeVita V, Hellman S, Rosenberg S. Cancer: Principles and Practice of Oncology, 7th edn, Philadelphia: Lippincott Williams and Wilkins, 2005:1423.